Therefore, we performed an immunohistochemistry-based evaluation of EZH2 expression in normal breast tissue in women with biopsy-confirmed benign breast disease (BBD) in the Nurses’ Health Studies and examined the association between EZH2 expression and subsequent breast cancer risk. This evidence concerns the gene EZH2 and breast cancer.